DEA Releases Fourth Temporary Extension of Telemedicine Flexibilities - paproviders.org
DEA has issued a fourth temporary extension of telemedicine flexibilities, continuing remote prescribing of controlled substances under current rules.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 16, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies, and practitioners who prescribe controlled substances via telemedicine. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the provided text; check the DEA announcement for the exact expiration date.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The DEA has extended temporary telemedicine flexibilities for the fourth time, allowing continued remote prescribing of controlled substances without an in-person medical evaluation.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies, and practitioners who prescribe controlled substances via telemedicine.
What you must do
Review the specific terms of the extension to ensure your telemedicine prescribing practices remain compliant; no immediate action required if already following existing flexibilities.
Deadline
Not specified in the provided text; check the DEA announcement for the exact expiration date.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Massachusetts Board of Pharmacy to Take a Big Step: Licensing Nonresident Pharmacies - hklaw.com
- Gov. DeWine orders Ohio Board of Pharmacy to ban synthetic kratom immediately - statenews.org
- Texas Telehealth Pharmacy Rule Signals a New Compliance Era: What Every Pharmacy Should Know About the Board’s Proposed Informed Consent Requirements - bipc.com
- California Enacts New Law Requiring California Licensure for Pharmacists-in-Charge of Nonresident Pharmacies — Effective July 1, 2026 - bipc.com
- Ohio Board of Pharmacy issues emergency ruling banning most kratom products for 180 days - Ohio Capital Journal